Evaluation of Patients With Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 Pandemic.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
11 2022
Historique:
accepted: 01 06 2022
pubmed: 16 6 2022
medline: 4 11 2022
entrez: 15 6 2022
Statut: ppublish

Résumé

To describe which variables were collected by rheumatologists to monitor patients with rheumatoid arthritis (RA) during teleconsultation and identify which ones have more impact on clinician intervention. Retrospective monocentric, routine care cross-sectional study including patients with RA seen in teleconsultation between March and September 2020. Available variables assessing disease status were collected in teleconsultation files. Clinician intervention was defined by treatment escalation and/or the need for a rapid face-to-face consultation or day hospitalization. One hundred forty-three patients with RA were included (116 females, mean age of 58 [SD 16] yrs, mean disease duration of 14 [SD 11] yrs). The presence or absence of patient self-reported RA flares was mentioned in all medical files, followed by the presence and/or the number of tender joints (76%), the duration of morning stiffness (66%), the number of pain-related nocturnal awakenings (66%) and the C-reactive protein (CRP) value (54%). Teleconsultation led to a clinician intervention in 22/143 patients (15%), representing 51% of patients with self-reported flares (22/43 patients). Therapeutic escalation was necessary in 13 patients and/or face-to-face consultation or day hospitalization were organized for 10 patients. Multivariate analysis identified RA flares (odds ratio [OR] 15.6, 95% CI 3.37-68.28) and CRP values > 10 mg/L (OR 3.32, 95% CI % 1.12-13.27) as the variables independently associated with clinician intervention. Our study identified patient-reported RA flares and increased CRP values as 2 red flags in teleconsultation, independently associated with therapeutic modification and/or the need for a rapid face-to-face consultation. These indicators may help clinicians' decision making in teleconsultation.

Identifiants

pubmed: 35705239
pii: jrheum.220073
doi: 10.3899/jrheum.220073
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1269-1275

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 by the Journal of Rheumatology.

Auteurs

Jérôme Avouac (J)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France. jerome.avouac@aphp.fr.

Anna Molto (A)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Camélia Frantz (C)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Sarah Wanono (S)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Elise Descamps (E)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Olivier Fogel (O)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Alice Combier (A)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Lucile Poiroux (L)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Corinne Miceli-Richard (C)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Yannick Allanore (Y)

J. Avouac, MD, PhD, A. Molto, MD, PhD, C. Frantz, MD, PhD, S. Wanono, MD, E. Descamps, MD, O. Fogel, MD, A. Combier, MD, L. Poiroux, MD, C. Miceli-Richard, MD, PhD, Y. Allanore, MD, PhD, Service de Rhumatologie, Hôpital Cochin, AP-HP, Centre Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH